Susquehanna Fundamental Investments’s AnaptysBio ANAB Stock Holding History

Susquehanna Fundamental Investments’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-44,785	Closed	-$593K	–	1068
2024 Q4	$593K	Buy	+44,785	New	+$1.08M	0.01%	828
2024 Q2	$1.81M	Buy	72,060 +17,855	+33%	+$416K	0.04%	432
2024 Q1	$1.22M	Buy	+54,205	New	+$1.28M	0.06%	314
2022 Q1	$223K	Sell	9,021 -198	-2%	-$5.99K	﹤0.01%	1333
2021 Q4	$320K	Sell	9,219 -6,000	-39%	-$190K	0.01%	1100
2021 Q3	$413K	Sell	15,219 -3,776	-20%	-$95.8K	0.01%	1288
2021 Q2	$493K	Buy	+18,995	New	+$455K	0.01%	1174
2021 Q1	–	Sell	-39,399	Closed	-$847K	–	1523
2020 Q4	$847K	Buy	+39,399	New	+$957K	0.02%	918

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Susquehanna Fundamental Investments's ANAB Position: Q1 2025 in Review

Susquehanna Fundamental Investments sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 44,785 shares — an estimated $593K sold.

Susquehanna Fundamental Investments first reported a position in ANAB in Q4 2020 and held it in 8 quarters. The position peaked at $1.81M in Q2 2024. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.

Susquehanna Fundamental Investments reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 44,785 AnaptysBio shares in Q1 2025, an estimated $593K.
Susquehanna Fundamental Investments first reported a position in AnaptysBio in Q4 2020 and held it in 8 quarters.
Susquehanna Fundamental Investments's AnaptysBio position peaked at $1.81M in Q2 2024.
153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q1 2025, filed 14 May 2025.